GRANULES INDIA LTD.-$ Q4 FY26 Results

Summary

Granules India Limited announced robust financial results for the fourth quarter and the full fiscal year ended March 31, 2026. In Q4FY26, revenue from operations grew 23% year-on-year to ₹14,706 Mn, with EBITDA rising 40% to ₹3,521 Mn and PAT increasing 33% to ₹2,016 Mn. For the full fiscal year, the company achieved a 20% year-on-year revenue growth, reaching ₹53,656 Mn, while EBITDA and PAT also grew significantly by 25% and 19% respectively. Chairman & Managing Director, Dr. Krishna Prasad Chigurupati, highlighted that this strong performance was driven by continued portfolio expansion, disciplined execution, and sustained advancement in Complex Generics and the Peptides CDMO platform. The company also reported an improved ROCE of 17.6% and a substantial reduction in net debt.

Key Highlights

1. 1

   Granules India Limited reported Q4FY26 revenue from operations of ₹14,706 Mn, a strong increase of 23% year-on-year.

2. 2

   For Q4FY26, EBITDA grew by 40% year-on-year to ₹3,521 Mn, while Profit After Tax (PAT) surged by 33% year-on-year to ₹2,016 Mn.

3. 3

   Full-year FY26 revenue from operations reached ₹53,656 Mn, marking a 20% growth compared to the previous fiscal year.

4. 4

   EBITDA for FY26 increased by 25% to ₹11,851 Mn, and PAT for the full year rose 19% to ₹5,950 Mn.

5. 5

   The company's Return on Capital Employed (ROCE) improved to 17.6% in FY26, up from 16.6% in FY25, reflecting enhanced efficiency.

6. 6

   Net debt significantly reduced by ₹3,040 Mn from Q4FY25 to stand at ₹4,021 Mn as of Q4FY26, resulting in a healthy Net debt to EBITDA ratio of 0.34x.

7. 7

   North America contributed 72% of revenue in Q4FY26, while Europe's revenue share grew to 17% in Q4FY26 from 8% in Q4FY25.